Advances allow for more accurate detection of metastatic disease.
Christopher J.D. Wallis, MD, PhD, FRCSC
Advertisement
Articles by Christopher J.D. Wallis, MD, PhD, FRCSC
Advances in receptor targeted PET imaging continue to refine the identification of metastatic disease.
Advertisement
Latest Updated Articles
Update on advanced imaging in prostate cancerPublished: June 11th 2021 | Updated:
Options increase for next-generation prostate cancer imagingPublished: September 10th 2020 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
Ronney Abaza, MD, discusses the next wave of advancements in robotic surgery
2
Urologist describes early experience with gemcitabine intravesical system in NMIBC
3
Martin M. Miner, MD, outlines data on testosterone therapy
4
LUGPA25: Martin M. Miner, MD, recaps findings from TRAVERSE, T4DM studies
5
